By now, we know that there are at least two potentially highly effective Covid-19 vaccines that may soon be available on an Emergency Use Authorization from the FDA. Fantastic news. When that happens, these vaccines will have to be distributed and administered. How will that work?
Let’s look at these parameters: Logistics, Priorities, Administration Process, Labor and Cost. I’m only going to look at this from the perspective of the United States. But we have to understand that this is a global concern. Continue reading
